Literature DB >> 578380

Cerebrospinal-fluid concentrations of nitrazepam in man.

L Kangas, J Kanto, T Siirtola, A Pekkarinen.   

Abstract

The concentrations of nitrazepam in the plasma and cerebrospinal-fluid (CSF) of 38 neurological patients were determined by gas chromatography 2-36 hours after a single 5 mg oral dose. The percentage ratio between the mean CSF and the plasma concentrations increased from 8.0% at 2 hours to 15.6% at 36 hours. This percentage rise was significant (P less than 0.001). The maximum concentration of nitrazepam in the plasma was 36.7 +/- 5.7 ng/ml (at 2 hours) and CSF 3.0 +/- 0.3 ng/ml (at 4 hours). During the beta-phase the half-life of nitrazepam in plasma was about 27 hours and in the CSF markedly longer about 68 hours, indicating a very slow elimination of nitrazepam from the CSF.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578380     DOI: 10.1111/j.1600-0773.1977.tb02125.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  9 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  CSF penetration and pharmacokinetics of midazolam.

Authors:  S Sjövall; J Kanto; J J Himberg; M Hovi-Viander; M Salo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of nitrazepam.

Authors:  L Kangas; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

5.  Long-term nitrazepam treatment in psychiatric out-patients with insomnia.

Authors:  L Kangas; J Kanto; V Lehtinen; J Salminen
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

6.  Human pharmacokinetics of nitrazepam: effect of age and diseases.

Authors:  L Kangas; E Iisalo; J Kanto; V Lehtinen; S Pynnönen; I Ruikka; J Salminen; M Sillanpää; E Syvälahti
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

7.  Transfer of nitrazepam across the human placenta.

Authors:  L Kangas; J Kanto; R Erkkola
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Entry of diazepam and its major matabolite into cerebrospinal fluid.

Authors:  D J Greenblatt; H R Ochs; B L Lloyd
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.